Friday, November 11, 2022 8:50:10 AM
-ASP Isotopes
Thu, November 10, 2022 at 7:30 AM
BOCA RATON, FL / ACCESSWIRE / November 10, 2022 / ASP Isotopes Inc. ("ASPI" or the "Company") (NASDAQ:ASPI), an advanced materials company dedicated to the development of technology and processes that will allow for the production of isotopes that may be used in several industries, today announced the pricing of its initial public offering of 1,250,000 shares of its common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $5.0 million before deducting underwriting discounts, commissions, and other offering expenses. In addition, ASPI has granted the underwriters a 45-day option to purchase up to an additional 187,500 shares of common stock at the public offering price per share, less the underwriting discounts and commissions, to cover over-allotments, if any.
The shares are expected to begin trading on the Nasdaq Capital Market LLC on November 10, 2022, under the ticker symbol "ASPI" and the offering is expected to close on or about November 14, 2022, subject to satisfaction of customary closing conditions.
Revere Securities LLC is acting as sole book-running manager for the offering.
A registration statement on Form S-1 (File No. 333-267392), was filed with the Securities and Exchange Commission ("SEC") and was declared effective on November 9, 2022. A final prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website at http://www.sec.gov. Electronic copies of the final prospectus relating to this offering, when available, from: Revere Securities LLC, 650 5th Ave, New York, NY 10019, United States. The final prospectus will also be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About ASP Isotopes Inc.
ASPI is an advanced materials company dedicated to the development of technology and processes that will allow for the production of isotopes that may be used in several industries. We have an exclusive license to use proprietary technology, the Aerodynamic Separation Process ("ASP technology") for the production, distribution, marketing and sale of all isotopes.
Our initial focus is on the production and commercialization of enriched Molybdenum-100 ("Mo-100"), and are constructing a first commercial-scale Mo-100 enrichment plant located in South Africa. We believe that the Mo-100 we may develop using the ASP technology has significant potential advantages for use in the preparation of nuclear imaging agents by radiopharmacies and others in the medical industry.
We may also seek to use the ASP technology to separate Silicon-28, which we believe has potential application in the quantum computing target end market, and Carbon-14, which we believe has potential application in the pharma/agrochemical target end market. In addition, we are considering future development of the ASP technology for the separation of Zinc-68, Ytterbium-176, Zinc-67, Nickel-64 and Xenon-136 for potential use in the healthcare target end market, and Uranium-235, Chlorine -37 and Lithium-6 for potential use in the nuclear energy target end market.
We were incorporated in Delaware in September 2021. Our principal executive offices are located at 433 Plaza Real, Suite 275, Boca Raton, Florida 33432, and our telephone number is (561) 709-3034. Our website address is www.aspisotopes.com.
Forward Looking Statements
This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the Company's offering filed with the SEC. Copies of these documents are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contacts
Robert Ainscow - Chief Financial Officer
ir@aspisotopes.com
Dave Gentry - RedChip
dave@redchip.com
SOURCE: ASP Isotopes Inc.
View source version on accesswire.com:
https://www.accesswire.com/724984/ASP-Isotopes-Inc-Announces-Pricing-of-Initial-Public-Offering-and-Nasdaq-Listing
Recent ASPI News
- ASP Isotopes Issues Letter to Stockholders • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- ASP Isotopes Inc. Enters Into Warrant Inducement Transaction for Approximately $5.5 Million in Gross Proceeds • GlobeNewswire Inc. • 04/09/2024 12:49:22 PM
- ASP Isotopes Inc. Enters Into a Contract with U.S.-Based Small Modular Reactor (SMR) Company for Project Focused on Engineering Design and Planning for Enrichment Facility for the Production of Advanced Nuclear Fuels • GlobeNewswire Inc. • 04/08/2024 01:22:05 PM
- ASP Isotopes Inc. Enters Into Purchase Agreement With a Leading Semiconductor Company for the Supply of Highly Enriched Electronic Gases • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- ASP Isotopes Inc. Announces Signing of Purchase Agreement for Offering of Convertible Notes by Quantum Leap Energy • GlobeNewswire Inc. • 02/29/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:47:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 12:27:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 12:17:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 12:10:40 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 12:05:38 PM
- ASP Isotopes Inc. Announces Increase in Offering Size of Convertible Notes by Quantum Leap Energy • GlobeNewswire Inc. • 02/22/2024 06:49:06 PM
- ASP Isotopes Inc. Announces Proposed Offering of Convertible Notes by Quantum Leap Energy • GlobeNewswire Inc. • 02/19/2024 01:00:00 AM
- ASP Isotopes Inc. Provides Update on Plans to Spin-Out its Wholly Owned Subsidiary, Quantum Leap Energy • GlobeNewswire Inc. • 02/16/2024 10:47:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:05:23 PM
- ASP Isotopes Inc. Provides Corporate Update • GlobeNewswire Inc. • 01/10/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:32:39 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/29/2023 05:15:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:11:13 PM
- ASP Isotopes Inc. Enters Into Memorandum of Understanding (MOU) With Second US-based Small Modular Reactor (SMR) Company To Supply High Assay Low Enriched Uranium (HALEU) • GlobeNewswire Inc. • 11/27/2023 01:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/21/2023 09:06:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:29:45 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/03/2023 08:15:20 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/02/2023 01:04:33 AM
- ASP Isotopes Inc. Enters Strategic Relationship With PET Labs Pharmaceuticals for the Distribution of Medical Isotopes • GlobeNewswire Inc. • 10/29/2023 11:35:35 PM
- ASP Isotopes Announces Closing of $9.1 Million Private Placement of Common Stock • GlobeNewswire Inc. • 10/27/2023 12:00:00 PM
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM